Soros Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-51,700
Closed -$3.52M 70
2024
Q3
$3.52M Buy
+51,700
New +$2.92M 0.85% 30
2021
Q4
Sell
-39,790
Closed -$3.8M 48
2021
Q3
$3.8M Hold
39,790
0.7% 21
2021
Q2
$4.95M Buy
39,790
+31,058
+356% +$3.71M 0.52% 36
2021
Q1
$1.15M Buy
+8,732
New +$1.2M 0.19% 43

Other funds holding EXAS

Soros Capital Management's EXAS Position: Q4 2024 in Review

Soros Capital Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 51,700 shares — an estimated $3.52M sold.

Soros Capital Management first reported a position in EXAS in Q1 2021 and held it in 4 quarters. The position peaked at $4.95M in Q2 2021. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Soros Capital Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Soros Capital Management sold 51,700 Exact Sciences shares in Q4 2024, an estimated $3.52M.
  • Soros Capital Management first reported a position in Exact Sciences in Q1 2021 and held it in 4 quarters.
  • Soros Capital Management's Exact Sciences position peaked at $4.95M in Q2 2021.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Soros Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.